Bristol-Myers Squibb plans fall campaign for Plavix

Goetzl, David
June 2000
Advertising Age;6/26/2000, Vol. 71 Issue 27, p36
Trade Publication
Reports that Bristol-Myers Squibb plans to launch a direct-to-consumer advertising campaign for Plavix, a heart attack and stroke prevention drug. Obstacles faced by Bristol-Myers before the ad campaign can begin, including the resolution of potential health side effects associated with Plavix; Production of the television and print ad campaign by Ogilvy & Mather Healthcare after CommonHealth and Bristol-Myers parted ways.


Related Articles

  • BMS ups DTC to fend off generic Plavix. Iskowitz, Marc // Medical Marketing & Media;Nov2006, Vol. 41 Issue 11, p28 

    The article reports on the plan of Bristol-Myers Squibb Co. to expand the direct-to-consumer advertising for its Plavix in the U.S. The move is intended to counter the impact of the launching of its generic. Lamberto Andreotti, executive vice president and president, claims that the campaign...

  • Untitled. Vecchione, Anthony // Medical Marketing & Media;Jan2009, Vol. 44 Issue 1, p10 

    The article announces the first non-English-language television (TV) campaign of Bristol-Myers Squibb Co. in the U.S. with advertisements in Mandarin on hepatitis B. It notes that the campaign features two chronic hepatitis B patients in 60-second TV spots with educational message on the...

  • Nuprin's smash hit. Sloan, Pat; Lafayette, Jon // Advertising Age;10/14/1991, Vol. 62 Issue 44, p3 

    Reports on the impact of an advertising campaign unveiled by Bristol-Myers Squibb Co. for its Nuprin drug on the sales of the ibuprofen pain reliever as of October 1991. Overview of the advertising campaign; Percentage share of the ibuprofen segment of the analgesic market held by Nuprin in...

  • Bristol boosts Tempra. Sloan, Pat // Advertising Age;10/14/1991, Vol. 62 Issue 44, p57 

    Reports on the consumer advertising campaign to be launched by J. Walter Thompson for the Tempra drug medication for children of Bristol-Myers Squibb Co. in 1991. Target market of the campaign; Theme of the campaign; Description of the product packaging of Tempra; Competitors of Tempra.

  • Keri Takes Firming Tack In `Last Chance' Revival. Bittar, Christine // Brandweek;12/13/99, Vol. 40 Issue 47, p8 

    Highlights the advertising campaign of Keri Skin Renewal Lotion from Bristol-Myers Squibb. Advertising budget; Competition with Nivea; Sales of Bristol-Myers; Tagline.

  • BMS shops $20 mil. account. Kim, Hank; Comiteau, Jennifer // Adweek Southeast Edition;11/03/97, Vol. 18 Issue 44, p67 

    Reports on rumors that Bristol-Myers Squibb has contacted at least one agency about its Vagistat-1 advertising account in 1997. Move as part of Bristol-Myers' reassessment of the remainder of its business currently at Wells; Reason behind this reappraisal.

  • Bristol-Myers Squibb sets Vagistat-1 review.  // Advertising Age;10/28/1996, Vol. 67 Issue 44, p1 

    Informs that Bristol-Myers Squibb Co. is conducting a review for Vagistate-1. Reduced time treatment for yeast infection; Awaiting approval from US Food and Drug Administration.

  • AZT overtaken.  // Business News New Jersey;02/02/98, Vol. 11 Issue 5, p2 

    Reports on `Zerit,' an anti-Acquired Immune Deficiency Syndrome (AIDS) drug from Bristol-Myers Squibb. Outcome of sales for Zerit; Positive attributes of the drug.

  • Excedrin Quick Tabs TV Spots Easy to Swallow. Bittar, Christine // Brandweek;9/2/2002, Vol. 43 Issue 31, p5 

    Reports on the marketing campaign to be used by Bristol Myers-Squibb for the launch of its Excedrin Quick Tabs, an analgesic that melts in the mouth. Description of the television spots; Tagline for the spots; Budget for the campaign; Sales expected for the product.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics